Add Yahoo as a preferred source to see more of our stories on Google. “That's tough. We already, you know, did something,” Evers told reporters last week when asked if he would sign the "bell-to-bell" ...

Synthekine Announces Clinical Trial Collaboration with Merck to Evaluate STK-012 In Combination with Keytruda® (Pembrolizumab) and Chemotherapy in Ongoing Randomized Phase 2 Trial in First-Line, PD-L1 ...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE ® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...

This is After Effects tutorial video to teach how to make Glitch effect. Apply to do a sort video that Cell (Dragon Ball) appears in tv to announces the Cell Games. Used: Fractal Noise and ...

ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug Authority for the treatment of metastatic non-small cell lung cancer, ...

You don’t need to be Willy Wonka or own a chocolate factory to make your own candy bars. It might sound intimidating, but chocolate bars are actually simple to make. Plus, doing it yourself gives you ...

Both trials are ongoing and will report on overall survival at a subsequent analysis. Findings showed the trial met its primary endpoint demonstrating a statistically significant and clinically ...

Interim results from the phase 2 NESCIO trial suggest combination neoadjuvant immunotherapy has efficacy in locally advanced clear cell renal cell carcinoma. Neoadjuvant combinations of ipilimumab or ...

A Wake Forest woman tried and over and over again to get Verizon to cancel her husband's phone service to no avail. She finally contacted 5 On Your Side and, within a week, the matter was resolved. A ...

BERLIN October 17, 2025 – Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival ...

Lurbinectedin, combined with atezolizumab or atezolizumab and hyaluronidase, is FDA-approved for ES-SCLC patients without disease progression post-induction therapy. Lurbinectedin is administered ...

An observational study was conducted across three Spanish hospitals to compare two glucocorticoid regimens in treating 151 patients newly diagnosed with giant cell arteritis (mean age, 74.6 years; 71% ...